Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.
2.

Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.

Gordon PH.

CNS Drugs. 2011 Jan;25(1):1-15. doi: 10.2165/11586000-000000000-00000. Review.

PMID:
21128691
3.

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole.

Corcia P, Gordon PH.

Ther Clin Risk Manag. 2012;8:359-66. doi: 10.2147/TCRM.S21981. Epub 2012 Aug 27.

4.

Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H.

Free Radic Biol Med. 2013 Dec;65:509-27. doi: 10.1016/j.freeradbiomed.2013.06.029. Epub 2013 Jun 21. Review.

5.

Amyotrophic lateral sclerosis.

Wijesekera LC, Leigh PN.

Orphanet J Rare Dis. 2009 Feb 3;4:3. doi: 10.1186/1750-1172-4-3. Review.

6.

Current view and perspectives in amyotrophic lateral sclerosis.

Mathis S, Couratier P, Julian A, Corcia P, Le Masson G.

Neural Regen Res. 2017 Feb;12(2):181-184. doi: 10.4103/1673-5374.200794. Review.

7.

Diagnostic investigation and multidisciplinary management in motor neuron disease.

Rocha JA, Reis C, Simões F, Fonseca J, Mendes Ribeiro J.

J Neurol. 2005 Dec;252(12):1435-47. Review.

PMID:
16362828
8.

The glutamate hypothesis in ALS: pathophysiology and drug development.

Blasco H, Mavel S, Corcia P, Gordon PH.

Curr Med Chem. 2014;21(31):3551-75. Review.

PMID:
25245510
9.

The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.

Kalmar B, Lu CH, Greensmith L.

Pharmacol Ther. 2014 Jan;141(1):40-54. doi: 10.1016/j.pharmthera.2013.08.003. Epub 2013 Aug 23. Review.

PMID:
23978556
10.

Genetics of amyotrophic lateral sclerosis: an update.

Chen S, Sayana P, Zhang X, Le W.

Mol Neurodegener. 2013 Aug 13;8:28. doi: 10.1186/1750-1326-8-28. Review.

11.

Roots to start research in amyotrophic lateral sclerosis: molecular pathways and novel therapeutics for future.

Harikrishnareddy D, Misra S, Upadhyay S, Modi M, Medhi B.

Rev Neurosci. 2015;26(2):161-81. doi: 10.1515/revneuro-2014-0057. Review.

PMID:
25720096
12.

Modelling amyotrophic lateral sclerosis: progress and possibilities.

Van Damme P, Robberecht W, Van Den Bosch L.

Dis Model Mech. 2017 May 1;10(5):537-549. doi: 10.1242/dmm.029058. Review.

13.

Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS).

Haidet-Phillips AM, Maragakis NJ.

Brain Res. 2015 Dec 2;1628(Pt B):343-50. doi: 10.1016/j.brainres.2015.06.035. Epub 2015 Jul 14. Review.

PMID:
26187754
14.

Therapeutic neuroprotective agents for amyotrophic lateral sclerosis.

Pandya RS, Zhu H, Li W, Bowser R, Friedlander RM, Wang X.

Cell Mol Life Sci. 2013 Dec;70(24):4729-45. doi: 10.1007/s00018-013-1415-0. Epub 2013 Jul 18. Review.

15.

Management and therapeutic perspectives in amyotrophic lateral sclerosis.

Mathis S, Couratier P, Julian A, Vallat JM, Corcia P, Le Masson G.

Expert Rev Neurother. 2017 Mar;17(3):263-276. doi: 10.1080/14737175.2016.1227705. Epub 2016 Sep 20.

PMID:
27644548
16.

State of the art and the dark side of amyotrophic lateral sclerosis.

Musarò A.

World J Biol Chem. 2010 May 26;1(5):62-8. doi: 10.4331/wjbc.v1.i5.62.

17.

Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments.

Tefera TW, Borges K.

Front Neurosci. 2017 Jan 10;10:611. doi: 10.3389/fnins.2016.00611. eCollection 2016. Review.

18.

Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis.

Vucic S, Kiernan MC.

Curr Mol Med. 2009 Apr;9(3):255-72. Review.

PMID:
19355908
19.

New therapy options for amyotrophic lateral sclerosis.

Gordon P, Corcia P, Meininger V.

Expert Opin Pharmacother. 2013 Oct;14(14):1907-17. doi: 10.1517/14656566.2013.819344. Epub 2013 Jul 16. Review.

PMID:
23855817
20.

Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights.

Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1161-70. doi: 10.1136/jnnp-2012-304019. Epub 2012 Dec 21. Review.

Supplemental Content

Support Center